These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6849186)

  • 21. Obturator foramen grafts: the preferable alternate route?
    Erath HG; Gale SS; Smith BM; Dean RH
    Am Surg; 1982 Feb; 48(2):65-9. PubMed ID: 6462077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes in the management of vascular prosthetic graft infections confined to the groin: a reappraisal.
    Taylor SM; Weatherford DA; Langan EM; Lokey JS
    Ann Vasc Surg; 1996 Mar; 10(2):117-22. PubMed ID: 8733862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autologous vein reconstruction in prosthetic graft infections.
    Sicard GA; Reilly JM; Doblas M; Orgaz A; Rubin BG; Flye MW; Thompson RW; Allen BT
    Eur J Vasc Endovasc Surg; 1997 Dec; 14 Suppl A():93-8. PubMed ID: 9467624
    [No Abstract]   [Full Text] [Related]  

  • 24. Criteria for evaluation of new arterial prostheses by comparing vein with dacron femoropopliteal bypasses.
    Reichle FA
    Surg Gynecol Obstet; 1978 May; 146(5):714-20. PubMed ID: 148109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Partial replacement of an infected arterial graft by a new prosthetic polytetrafluoroethylene segment: a new therapeutic option.
    Miller JH
    J Vasc Surg; 1993 Mar; 17(3):546-58. PubMed ID: 8445751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autogenous vein grafts for femorofemoral revascularization in contaminated or infected fields.
    Hakaim AG; Hertzer NR; O'Hara PJ; Krajewski LP; Beven EG
    J Vasc Surg; 1994 May; 19(5):912-5. PubMed ID: 8170047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutical options in partial infected aorto- bifemoral prosthetic grafts].
    Burcoveanu C; Popa R; Hău G; Petrea R; Nabhan K
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(2):459-62. PubMed ID: 14755961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A modified method for management of prosthetic graft infections involving an anastomosis to the common femoral artery.
    Calligaro KD; Veith FJ; Gupta SK; Ascer E; Dietzek AM; Franco CD; Wengerter KR
    J Vasc Surg; 1990 Apr; 11(4):485-92. PubMed ID: 2139143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cryopreserved saphenous vein allogenic homografts: an alternative conduit in lower extremity arterial reconstruction in infected fields.
    Fujitani RM; Bassiouny HS; Gewertz BL; Glagov S; Zarins CK
    J Vasc Surg; 1992 Mar; 15(3):519-26. PubMed ID: 1538509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Factors determining late patency of aortobifemoral bypass graft].
    Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanov PL; Velimirović DB; Marković MM; Pejkić SA; Vukotić AM
    Srp Arh Celok Lek; 1997; 125(1-2):24-35. PubMed ID: 17974352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Aorto-ilio-femoral venous grafts (author's transl)].
    Cormier JM; Lagneau P; Firouzabadie H
    J Chir (Paris); 1977; 114(6):397-412. PubMed ID: 608847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of infection of major amputation stumps after failed femorodistal grafts.
    Rubin JR; Yao JS; Thompson RG; Bergan JJ
    Surgery; 1985 Oct; 98(4):810-5. PubMed ID: 4049252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In situ fresh allograft replacement of an infected aortic prosthetic graft: eighteen months' follow-up.
    Bahnini A; Ruotolo C; Koskas F; Kieffer E
    J Vasc Surg; 1991 Jul; 14(1):98-102. PubMed ID: 2061963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of autologous spiral vein grafts for vascular reconstructions in contaminated fields.
    Fowl RJ; Martin KD; Sax HC; Kempczinski RF
    J Vasc Surg; 1988 Oct; 8(4):442-6. PubMed ID: 3172380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternative autogenous vein grafts to the inadequate saphenous vein.
    Harris RW; Andros G; Salles-Cunha SX; Dulawa LB; Oblath RW; Apyan R
    Surgery; 1986 Nov; 100(5):822-7. PubMed ID: 3775652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iatrogenic entrapment of femoropopliteal saphenous vein bypass grafts by the gastrocnemius muscle.
    Brener BJ; Alpert J; Brief DK; Parsonnet V
    Surgery; 1975 Nov; 78(5):668-74. PubMed ID: 1188609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fate of aortic graft removal.
    Martin-Paredero V; Busuttil RW; Dixon SM; Baker JD; Machleder H; Moore WS
    Am J Surg; 1983 Aug; 146(2):194-7. PubMed ID: 6881440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of biosynthetic prosthesis (Omniflow II®) to replace infected infrainguinal prosthetic grafts--first results.
    Töpel I; Betz T; Uhl C; Wiesner M; Bröckner S; Steinbauer M
    Vasa; 2012 May; 41(3):215-20. PubMed ID: 22565623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of autologous graft and human umbilical vein graft in femorocrural bypasses--a preliminary report.
    Rondhuis JJ; van Iersel JG; Taks AC
    Neth J Surg; 1985 Apr; 37(2):50-3. PubMed ID: 4000519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term results of the treatment of aortic graft infection by in situ replacement with femoral popliteal vein grafts.
    Ali AT; Modrall JG; Hocking J; Valentine RJ; Spencer H; Eidt JF; Clagett GP
    J Vasc Surg; 2009 Jul; 50(1):30-9. PubMed ID: 19563952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.